Most Popular Brands: Low Dose Naltrexone (LDN)
Naltrexone, in low doses such as 3mg to 4.5mg, has been found to boost the immune system in MS, autoimmune diseases, and central nervous system disorders. Naltrexone was FDA-approved in 1985 for the management of alcohol dependence and opioid dependence at 50mg doses.
Read more...
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Slow my ALS progress | 27 |
|
|
|
|
6 | |
| Other | 5 |
|
|
2 | |||
| Fatigue | 2 |
|
1 | ||||
| Slow down ALS symptoms | 1 | 0 | |||||
| hopeful that it slows progression | 1 | 0 | |||||
| improved breathing | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Doctor's advice
|
4 | 33% |
|
|
Other
|
4 | 33% |
|
|
Did not seem to work
|
2 | 17% |
|
|
Side effects too severe
|
2 | 17% |
|
|
Not indicated
|
1 | 8% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 23, 2009.